subcutan lisurid infus parkinson diseas respons administr patient thirty-eight parkinsonian patient motor fluctuat dyskinesia chronic levodopa therapi subcutan lisurid infus sli hospit combin treatment lisurid infus micrograms/h oral levodopa decarboxylas inhibitor mg/day mark initi improv mobil mean reduct hour mean month patient improv respect assess chronic treatment dyskinesia period difficult levodopa schedul dose patient lisurid treatment inefficaci high incid psychiatr side-effect major factor lisurid infus popul sever parkinsonian patient mani inconveni pump technic requir long-term util patient sli reason result motor function sever parkinsonian patient sli dyskinesia psychiatr advers effect long-term use approach continu dopaminerg stimul use therapeut strategi stage diseas 